The Health Ministry said current research around puberty blocker drugs was of “poor quality” and it will hold a public consultation on its continued use.
The review stated that there is insufficient evidence to demonstrate the long-term benefits of medicalizing children who want to identify as a different gender.
The court allowed the Vulnerable Child Protection Act, a state law forbidding so-called gender-affirming care for minors, to take effect pending appeals.